Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Magalashvili

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
European Neurology|January 3, 2023
Radiological Disease Activity in Secondary Progressive Multiple SclerosisDaniela Noa Zohar, David Magalashvili, Sapir Dreyer-Alster, et al.
The Israel Medical Association Journal : IMAJ|June 9, 2012
Multiple sclerosis in Israeli children: incidence, an clinical, cerebrospinal fluid and magnetic resonance imaging findingsAnat Achiron, Ben-Zion Garty, Shay Menascu, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 28, 2025
Positive impact of cladribine tablets on reducing brain atrophy in patients with relapsing-remitting multiple sclerosis: A longitudinal studyAnat Achiron, Yehuda Warszawer, Yael Nissan, et al.
Plos One|August 30, 2019
Cognitive function in multiple sclerosis: A long-term look on the bright sideYermi Harel, Alon Kalron, Shay Menascu, et al.
Journal of Neurology|July 30, 2020
Parity and disability progression in relapsing-remitting multiple sclerosisAnat Achiron, Alon Ben-David, Michael Gurevich, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 13, 2021
SARS-CoV-2 memory B and T cell profiles in mild COVID-19 convalescent patientsMichael Gurevich, Rina Zilkha-Falb, Polina Sonis, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|October 25, 2022
COVID-19 Alpha Variant (B.1.1.7): Humoral, memory B and T cells in COVID-19 pediatric convalescentsMichael Gurevich, Rina Zilkha-Falb, Polina Sonis, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 2, 2018
Residual disability after severe relapse in people with multiple sclerosis treated with disease-modifying therapyAnat Achiron, Ida Sarova-Pinhas, David Magalashvili, et al.
Multiple Sclerosis and Related Disorders|February 12, 2021
Definitions of primary-progressive multiple sclerosis trajectories by rate of clinical disability progressionAnat Achiron, Sapir Dreyer-Alster, Michael Gurevich, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 26, 2014
Effect of Alfacalcidol on multiple sclerosis-related fatigue: A randomized, double-blind placebo-controlled studyAnat Achiron, Uri Givon, David Magalashvili, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
European Neurology|January 3, 2023
Radiological Disease Activity in Secondary Progressive Multiple SclerosisDaniela Noa Zohar, David Magalashvili, Sapir Dreyer-Alster, et al.
The Israel Medical Association Journal : IMAJ|June 9, 2012
Multiple sclerosis in Israeli children: incidence, an clinical, cerebrospinal fluid and magnetic resonance imaging findingsAnat Achiron, Ben-Zion Garty, Shay Menascu, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 28, 2025
Positive impact of cladribine tablets on reducing brain atrophy in patients with relapsing-remitting multiple sclerosis: A longitudinal studyAnat Achiron, Yehuda Warszawer, Yael Nissan, et al.
Plos One|August 30, 2019
Cognitive function in multiple sclerosis: A long-term look on the bright sideYermi Harel, Alon Kalron, Shay Menascu, et al.
Journal of Neurology|July 30, 2020
Parity and disability progression in relapsing-remitting multiple sclerosisAnat Achiron, Alon Ben-David, Michael Gurevich, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 13, 2021
SARS-CoV-2 memory B and T cell profiles in mild COVID-19 convalescent patientsMichael Gurevich, Rina Zilkha-Falb, Polina Sonis, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|October 25, 2022
COVID-19 Alpha Variant (B.1.1.7): Humoral, memory B and T cells in COVID-19 pediatric convalescentsMichael Gurevich, Rina Zilkha-Falb, Polina Sonis, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 2, 2018
Residual disability after severe relapse in people with multiple sclerosis treated with disease-modifying therapyAnat Achiron, Ida Sarova-Pinhas, David Magalashvili, et al.
Multiple Sclerosis and Related Disorders|February 12, 2021
Definitions of primary-progressive multiple sclerosis trajectories by rate of clinical disability progressionAnat Achiron, Sapir Dreyer-Alster, Michael Gurevich, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 26, 2014
Effect of Alfacalcidol on multiple sclerosis-related fatigue: A randomized, double-blind placebo-controlled studyAnat Achiron, Uri Givon, David Magalashvili, et al.
Pageof 4